Portal de Periódicos da CAPES

Artigo Acesso aberto Produção Nacional Revisado por pares

BIBTEX RIS

COVID-19: Hypernatremia is a significant predictor of mortality

2023; Hospital de Clinicas de Porto Alegre ; Universidade Federal do Rio Grande do Sul (UFRGS); Linguagem: Inglês

10.22491/2357-9730.124547

2357-9730

Jonas Michel Wolf, Helena Petek, Juçara Gasparetto Maccari, Luiz Antônio Nasi,

Electrolyte and hormonal disorders

Introduction: Coronavirus disease 2019 (COVID-19) pandemic spread rapidly, creating a worrisome scenario worldwide.In hospitalized patients, dysnatremia (hyponatremia and/or hypernatremia) is the most common electrolyte disturbance, reported in 30-40% of cases and associated with a poor prognosis.This study aimed to evaluate the association between dysnatremia and mortality in hospitalized patients infected with SARS-COV-2.Methods: Retrospective longitudinal study that analyzed data from hospital records of 1,000 patients with COVID-19 (median age, 62.5 years; 57.1% men), including 109 (10.9%) deaths.Kaplan-Meier survival curves and Cox proportional hazard models with Hazard Ratio (HR) with 95% confidence intervals (95%CI) were applied to confirm the association between dysnatremia (hyponatremia and/or hypernatremia) and death.Results: Hypernatremia was detected in 83 (76.1%) of the patients who died, with a cumulative reduction in survival (p < 0.01) and a 2.42-fold increased mortality risk (95%CI: 1.45-2.91).In the multivariable analysis, hypernatremia was the main factor associated with increased mortality (HR: 1.50; 95%CI: 1.23-1.81).Long length of stay (LOS) (HR: 1.54; 95%CI: 1.21-1.78),old age (HR: 1.63; 95%CI: 1.28-1.88),and chronic kidney disease (HR: 1.77; 95%CI: 1.21-3.30)were also associated with death. Conclusion:Hypernatremia during hospitalization is an important risk factor for poor prognosis and an increased mortality risk.LOS, old age, and chronic kidney disease could also be used for risk stratification in patients with COVID-19.